In the news October 13, 2026
How Ontario slashed wait times for cancer treatments
By Dr. Bettina Hamelin One year ago, the Ontario government made a decision: Patients shouldn’t have to wait up to […]
All news
Stay informed with the latest press releases, industry updates, and insights from Innovative Medicines Canada.
Filter by
In the news October 08, 2026
Canada is losing the race for clinical trials – and patients are paying the price
By Dr. Bettina Hamelin Canada has long punched above its weight in clinical trial activity: the rigorous, multi-stage research studies […]
In the news July 21, 2026
Opinion: It’s faster to fly a human around the moon than to get a new drug to Canadians
By Dr. Bettina Hamelin Article originally published on Healthing.ca, July 21, 2026. This spring, Canada made history when astronaut Jeremy Hansen […]
In the news June 25, 2026
Canada’s wait for new medicines is long — and about to get longer
By Dr. Bettina Hamelin Article originally published on healthinsight.ca, June 25, 2026. Global drug policy changes are making it increasingly difficult […]
In the news June 11, 2026
Canada’s innovation gap: why your access to medicines is at risk
By Dr. Bettina Hamelin Article originally published on the Toronto Star, June 11, 2026. There’s a quiet crisis unfolding behind closed […]
In the news June 09, 2026
The case for fixing Canada’s innovation gap
The global rules governing how innovative medicines are valued and priced are being rewritten— and Canada must be ready. By […]
In the news April 28, 2026
A critical moment for Canada: Ensuring world-leading access to innovative medicines
In this episode of From the Burgundy Chairs, Santis Health Senior Advisor Avis Favaro sits down with Dr. Bettina Hamelin, […]
In the news April 22, 2026
The task force that could get things right for Canadian patients
Article by Bettina Hamelin originally published in the Hill Times Health Policy Briefing, page 21, April 22, 2026. By Dr. […]
In the news April 10, 2026
Interview with Bettina Hamelin in Investment Reports
As originally published in Investment Reports, featured by Newsweek on 10th April 2026 Over the past year, have you seen […]
In the news March 24, 2026
Your access to medicines is at risk
As originally published by Bettina Hamelin on LinkedIn on 24 March 2026 By Bettina Hamelin Recent global drug policy changes […]
In the news February 11, 2026
Canada can’t afford to wait for leadership in pharmaceutical innovation
The new U.S. drug pricing approach forces a choice, but it doesn’t limit our ambition. We need a new, coordinated […]
In the news February 10, 2026
Canada’s life sciences potential: Stalled by access delays and regulatory hurdles
As originally published in NPC Healthbiz Weekly (Issue #356) in February 2026. Canada has the talent and industrial capacity to […]
